Show Stocks and Investing Publications • Fri, July 30, 2021
Salveen Richter Downgraded (AGIO) to Strong Sell and Decreased Target to $39 on, Jul 30th, 2021
ngraded-agio-to-strong-sell-and-decreased-target-to-39-on-jul-30th-2021.html
Stocks and Investing on Sun, Oct 27th, 2024 by 
WOPRAISalveen Richter of Goldman Sachs, Downgraded "Agios Pharmaceuticals, Inc." (AGIO) to Strong Sell and Decreased Target from $58 to $39 on, Jul 30th, 2021.
Salveen has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021
This is the rating of the analyst that currently disagrees with Salveen
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $65 on, Friday, April 30th, 2021
Like: 👍